Autor:	Amit Ghanekar, Tapan Saikia, Reetu Jain, Vipul Sheth, Adwaita Gore
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty Mobilization business.industry Plerixafor medicine.disease Single Center Lymphoma Haematopoiesis immune system diseases hemic and lymphatic diseases Internal medicine medicine Autologous transplantation In patient Stem cell business medicine.drug
Zdroj:	Journal of Clinical Oncology. 33:e18011-e18011
ISSN:	1527-7755 0732-183X
Popis:	e18011 Background: The combination of plerixafor & GCSF is approved for mobilization of hematopoietic stem cells for autologous transplantation in patients with lymphoma & myeloma whose cells who m...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5d84450f9e0b27825e8cc26f89238f5a https://doi.org/10.1200/jco.2015.33.15_suppl.e18011 Zobrazit plný text záznamu